Last reviewed · How we verify

Hydrating Cream

Chang Gung Memorial Hospital · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Hydrating Cream is a Small molecule drug developed by Chang Gung Memorial Hospital. It is currently FDA-approved.

Hydrating Cream, also known as SNG100, is a topical cream being studied for the treatment of moderate atopic dermatitis, among other skin conditions. The exact mechanism of action of Hydrating Cream is currently unknown.

At a glance

Generic nameHydrating Cream
SponsorChang Gung Memorial Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Hydrating Cream

What is Hydrating Cream?

Hydrating Cream is a Small molecule drug developed by Chang Gung Memorial Hospital.

Who makes Hydrating Cream?

Hydrating Cream is developed and marketed by Chang Gung Memorial Hospital (see full Chang Gung Memorial Hospital pipeline at /company/chang-gung-memorial-hospital).

What development phase is Hydrating Cream in?

Hydrating Cream is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing